Medique Medi-Acid Reducer 150

Manufacturer: Unifirst First Aid Corporation
Effective date: 2019-08-26
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-02 00:14:21

Label at a glance#

ProductMedique Medi-Acid Reducer 150

Active ingredientRANITIDINE HYDROCHLORIDE

Label structure11 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Dosage and administration

Adults and children (12 years and over) to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily (do not take more than 2 tablets in 24 hours) do not chew tablet Children under 12 years: ask a doctor

Contacts and useful links#

PhoneLabel contact1-800-634-7680

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 150 mg (as ranitidine hydrochloride, USP 168 mg)

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

relieves heartburn associated with acid indigestion and sour stomach
prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers.

Do not use

OTC - DO NOT USE SECTION

if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
with other acid reducers
if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

had heartburn over 3 months. This may be a sign of a more serious condition.
heartburn with lightheadedness, sweating or dizziness
chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
frequent chest pain
frequent wheezing, particularly with heartburn
unexplained weight loss
nausea or vomiting
stomach pain

Stop use and ask a doctor if

OTC - STOP USE SECTION

your heartburn continues or worsens
you need to take this product for more than 14 days

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children (12 years and over)

to relieve symptoms, swallow 1 tablet with a glass of water
to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
can be used up to twice daily (do not take more than 2 tablets in 24 hours)
do not chew tablet

Children under 12 years: ask a doctor

Other information

OTHER SAFETY INFORMATION

store at room temerature 68°F to 77°F (20°C to 25°C)
tamper evident sealed blister pack(s)
do not use if individual blister unit is open or torn
avoid excessive heat or humidity
this product is sodium and sugar free

Inactive ingredients

INACTIVE INGREDIENT SECTION

carnauba wax, colloidal silicon dioxide, cool vanilla mint flavor, FD&C blue #1, hypromellose, magnesium stearate, microcrystalline cellulose, polydextrose, titanium dioxide

Questions or comments?

OTC - QUESTIONS SECTION

1-800-634-7680

Medi-Acid Reducer 150 Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Medique®

Cool Mint

Medi-Acid Reducer 150

Maximum Strength

Acid Blocker/Reducer

Ranitidine 150mg

Compare to the active ingredient in Zantac 150®

Registered Trademark of Boehringer Ingelheim

Tamper Evident Blister Pack

24 Tablets

Medique Medi-Acid Reducer label

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Medique Medi-Acid Reducer 150
Ranitidine
POLYDEXTROSE
RANITIDINE HYDROCHLORIDE
CARNAUBA WAX
SILICON DIOXIDE
HYPROMELLOSES
FD&C BLUE NO. 1
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
TITANIUM DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
47682-325	47682-325-64

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
POLYDEXTROSE	VH2XOU12IE	IACT
RANITIDINE HYDROCHLORIDE	BK76465IHM	ACTIM
CARNAUBA WAX	R12CBM0EIZ	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
HYPROMELLOSES	3NXW29V3WO	IACT
FD&C BLUE NO. 1	H3R47K3TBD	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A200172-001	RANITIDINE HYDROCHLORIDE	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL			2012-05-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A200172-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2012-05-31	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
9107fbc1-0cce-dab0-e053-2995a90a34cc			6d0cfe7c-8870-cbdb-e053-2a91aa0a43b7	2019-08-26	Warnings	Exact identifier spl id: 9107fbc1-0cce-dab0-e053-2995a90a34cc spl set id: 6d0cfe7c-8870-cbdb-e053-2a91aa0a43b7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.